Claims for Patent: 10,508,170
✉ Email this page to a colleague
Summary for Patent: 10,508,170
| Title: | Crystalline wholly aromatic polyester and method for manufacture thereof |
| Abstract: | [Problem] Provided is a crystalline wholly aromatic polyester which is a polycondensate of an aromatic dicarboxylic acid and an aromatic diol and method for manufacture thereof.[Solving means] A crystalline wholly aromatic polyester according to the present invention is a polycondensate of an aromatic dicarboxylic acid and an aromatic diol, wherein a structual unit derived from the aromatic dicarboxylic acid comprises a structural unit represented by formula (1): and wherein a structual unit derived from aromatic diol comprises a structural unit represented by formula (4): |
| Inventor(s): | Masatoshi Ando |
| Assignee: | Eneos Corp |
| Application Number: | US15/562,555 |
Details for Patent 10,508,170
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Takeda Pharmaceuticals U.s.a., Inc. | VPRIV | velaglucerase alfa | For Injection | 022575 | February 26, 2010 | 10,508,170 | 2036-03-28 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 10,508,170
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| China | 107531892 | ⤷ Start Trial |
| European Patent Office | 3279234 | ⤷ Start Trial |
| Japan | 6505829 | ⤷ Start Trial |
| Japan | WO2016158839 | ⤷ Start Trial |
| Taiwan | 201700528 | ⤷ Start Trial |
| United States of America | 2018105641 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
